These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 24135571)

  • 1. Current status of syphilis vaccine development: need, challenges, prospects.
    Cameron CE; Lukehart SA
    Vaccine; 2014 Mar; 32(14):1602-9. PubMed ID: 24135571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine development for syphilis.
    Lithgow KV; Cameron CE
    Expert Rev Vaccines; 2017 Jan; 16(1):37-44. PubMed ID: 27328030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.
    Parveen N; Fernandez MC; Haynes AM; Zhang RL; Godornes BC; Centurion-Lara A; Giacani L
    Vaccine; 2019 Mar; 37(13):1807-1818. PubMed ID: 30797635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of syphilis immunology and Treponema pallidum subsp. pallidum biology to improve clinical management and design a broadly protective vaccine: study protocol.
    Osias E; Hung P; Giacani L; Stafylis C; Konda KA; Vargas SK; Reyes-Díaz EM; Comulada WS; Haake DA; Haynes AM; Caceres CF; Klausner JD
    BMC Infect Dis; 2020 Jun; 20(1):444. PubMed ID: 32576149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress towards an effective syphilis vaccine: the past, present and future.
    Cullen PA; Cameron CE
    Expert Rev Vaccines; 2006 Feb; 5(1):67-80. PubMed ID: 16451109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum.
    Lithgow KV; Hof R; Wetherell C; Phillips D; Houston S; Cameron CE
    Nat Commun; 2017 Feb; 8():14273. PubMed ID: 28145405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with a tri-antigen syphilis vaccine significantly attenuates chancre development, reduces bacterial load, and inhibits dissemination of Treponema pallidum.
    Lukehart SA; Molini B; Gomez A; Godornes C; Hof R; Fernandez MC; Pitner RA; Gray SA; Carter D; Giacani L; Cameron CE
    Vaccine; 2022 Dec; 40(52):7676-7692. PubMed ID: 36376214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits.
    Zhao F; Zhang X; Liu S; Zeng T; Yu J; Gu W; Zhang Y; Chen X; Wu Y
    Sci China Life Sci; 2013 Feb; 56(2):174-80. PubMed ID: 23334700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The continuing threat of syphilis in pregnancy.
    Moline HR; Smith JF
    Curr Opin Obstet Gynecol; 2016 Apr; 28(2):101-4. PubMed ID: 26871538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syphilis Vaccine Development: Requirements, Challenges, and Opportunities.
    Cameron CE
    Sex Transm Dis; 2018 Sep; 45(9S Suppl 1):S17-S19. PubMed ID: 29528992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the invasion process and immune-protective evaluation of Tp0971, a membrane lipoprotein from
    Zhang X; Duan J; Wang Y; Xie B; Zhou J; Zhao S; Yin W; Liu P; Zhao F
    Microbiol Spectr; 2023 Dec; 11(6):e0004723. PubMed ID: 37855609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancements in the development of nucleic acid vaccines for syphilis prevention and control.
    Li S; Li W; Jin Y; Wu B; Wu Y
    Hum Vaccin Immunother; 2023 Aug; 19(2):2234790. PubMed ID: 37538024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notes on syphilis vaccine development.
    Kojima N; Konda KA; Klausner JD
    Front Immunol; 2022; 13():952284. PubMed ID: 35967432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with Tp0954, an adhesin of
    He Y; Chen D; Fu Y; Huo X; Zhao F; Yao L; Zhou X; Qi P; Yin H; Cao L; Ling H; Zeng T
    Front Immunol; 2023; 14():1130593. PubMed ID: 36993963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syphilis vaccine: challenges, controversies and opportunities.
    Ávila-Nieto C; Pedreño-López N; Mitjà O; Clotet B; Blanco J; Carrillo J
    Front Immunol; 2023; 14():1126170. PubMed ID: 37090699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Potential Syphilis Vaccine Candidates Inhibit Dissemination of
    Xu M; Xie Y; Zheng K; Luo H; Tan M; Zhao F; Zeng T; Wu Y
    Front Immunol; 2021; 12():759474. PubMed ID: 34899710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Protective Ability of the Treponema pallidum subsp.
    Haynes AM; Godornes C; Ke W; Giacani L
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31182617
    [No Abstract]   [Full Text] [Related]  

  • 18. Workshop on the biology of the treponemes.
    Krause RM
    J Infect Dis; 1972 Mar; 125(3):332. PubMed ID: 4622713
    [No Abstract]   [Full Text] [Related]  

  • 19. [Attempts at developing a syphilis vaccine (author's transl)].
    Metzger M
    Dermatol Monatsschr; 1979 Apr; 165(4):257-63. PubMed ID: 378724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global challenge of antibiotic-resistant Treponema pallidum.
    Stamm LV
    Antimicrob Agents Chemother; 2010 Feb; 54(2):583-9. PubMed ID: 19805553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.